JPRN-UMIN000032686已完成未知
A Biomarker Analysis of Nivolumab in Previously Treated Advanced Gastric Cancer(WJOG10417GTR) - A Biomarker Analysis of Nivolumab in Previously Treated Advanced Gastric Cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Synchronous or metachronous malignancies 2)A positive test result for any of the followings: Human immunodeficiency virus antibody, hepatitis B surfaces (HBs) antigen, or hepatitis C virus antibody 3)Positive test result for either HBs antibody or hepatitis B core antibody, with a detectable level of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) even in case of negative HBs antigen test 4)Judged to be incapable of providing consent for certain reasons, such as concurrent dementia
研究者
相似试验
已完成
不适用
Biomarker analysis: Phase II study of nivolumab + abemaciclib + endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer (NEWFLAME) WJOG11418B-TRHormone receptor positive and HER2-negative advanced breast cancerJPRN-UMIN000036970West Japan Oncology Group53
招募中
2 期
The early assessment of the response to Nivolumab of renal cell carcinoma by FDG PET/CTrenal cell carcinomaJPRN-UMIN000034674Yokohama City University Graduate School of Medicine45
已完成
2 期
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)Hodgkin DiseaseNCT02181738Bristol-Myers Squibb294
进行中（未招募）
2 期
Phase II study Nivolumab in previously treated non-small-cell lung cancer subjects to evaluate the peripheral blood mononuclear cell immunological biomarkerJPRN-jRCTs031180013Kagamu Hiroshi60
已完成
不适用
Phase II study Nivolumab in previously treated non-small-cell lung cancer subjects to evaluate the peripheral blood mononuclear cell immunological biomarkernon-small-cell lung cancerJPRN-UMIN000028468orst East Japan Study Group(NEJSG)60